A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. (Q33382993)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. |
scientific article |
Statements
1 reference
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. (English)
1 reference
Cancer and Leukemia Group B
1 reference
Everett E Vokes
1 reference
Ramaswamy Govindan
1 reference
Xiaofei Wang
1 reference
Maria Q Baggstrom
1 reference
Susan Burdette-Radoux
1 reference
Lydia Hodgson
1 reference
Mark R Green
1 reference
1 February 2009
1 reference
1 reference
220-226
1 reference
Identifiers
1 reference
1 reference